Determination of Rivaroxaban by Different Factor Xa Specific Chromogenic Substrate Assays: Reduction of Interassay Variability

Journal of Thrombosis and Thrombolysis - Netherlands
doi 10.1007/s11239-011-0622-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Rivaroxaban: An Oral Direct Inhibitor of Factor Xa

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2008English

The Contribution of Factor Xa to Exosite-Dependent Substrate Recognition by Prothrombinase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Reversal of Rivaroxaban-Induced Alterations on Hemostasis by Different Coagulation Factor Concentrates

Circulation Journal
MedicineCardiovascular MedicineCardiology
2015English

Safety, Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor – In Elderly Chinese Subjects

Thrombosis and Haemostasis
Hematology
2010English

Factor Xa Inhibitors

2016English

Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa Inhibitors

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Phosphatidylserine and Factor VA Regulate Factor Xa Structure

Biophysical Journal
Biophysics
2014English

Discovery of a Novel, Potent, and Specific Family of Factor Xa Inhibitors via Combinatorial Chemistry

Biochemistry
Biochemistry
1998English

Mapping of the Factor Xa Binding Site on Factor Va by Site-Directed Mutagenesis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy